P2.03a-060 Favorable Survival of TTF-1 Expression in Pemetrexed Based Treated NSCLC Patients: Topic: Clinical Trials

Autor: Steppert, Claus, Leistner, Rumo, Brueckl, Wolfgang, Krugmann, Jens, Ficker, Joachim, Wuerflein, Dieter
Zdroj: In Journal of Thoracic Oncology January 2017 12(1) Supplement:S925-S926
Databáze: ScienceDirect